RT Journal Article
SR Electronic
T1 Interplay of Phase II Enzymes and Transporters in Futile Cycling: Influence of Multidrug Resistance-Associated Protein 2-Mediated Excretion of Estradiol 17β-d-Glucuronide and Its 3-Sulfate Metabolite on Net Sulfation in Perfused TR− and Wistar Rat Liver Preparations
JF Drug Metabolism and Disposition
JO Drug Metab Dispos
FD American Society for Pharmacology and Experimental Therapeutics
SP 769
OP 780
DO 10.1124/dmd.109.029959
VO 38
IS 5
A1 Huadong Sun
A1 Ying-Ying Zeng
A1 K. Sandy Pang
YR 2010
UL http://dmd.aspetjournals.org/content/38/5/769.abstract
AB The hepatic disposition of estradiol 17β-d-glucuronide (E217G), a substrate of the organic anion-transporting polypeptides Oatp1a1, Oatp1a4, and Oatp1b2, was investigated in Wistar and TR− [multidrug resistance-associated protein (Mrp) 2-mutant] rats to elucidate how absence of Mrp2, the major excretory transporter for both E217G and its 3-sulfate metabolite (E23S17G), affected the net sulfation. With absence of Mrp2, lower microsomal desulfation activity and higher Mrp3 but unchanged immunoreactive protein expression of other transporters (Oatps and Mrp4) and estrogen sulfotransferase were found in TR− rats. In recirculating, perfused liver preparations, the rapid decay of E217G and sluggish appearance of low levels of E23S17G in perfusate for Wistar livers were replaced by a protracted, biexponential decay of E217G and greater accumulation of E23S17G, whose levels reached plateaus upon the almost complete obliteration of biliary excretion of E217G and E23S17G in the TR− liver. Much higher amounts of E217G (28×) and E23S17G (11×) in liver and reduced net sulfation (40 ± 6 from 77 ± 6% dose, P < 0.05) were observed at 2 h for the TR− versus the Wistar rats. With use of a physiologically based pharmacokinetic model, analytical solutions for the areas under the curve for the precursor and metabolite were obtained to reveal how enzyme- and transporter-mediated processes affected the hepatic disposition of the precursor and metabolite in futile cycling. The analytical solutions were useful to explain transporter-enzyme interplay in futile cycling and predicted that a shutdown of Mrp2 function led to decreased net sulfation of E217G by raising the intracellular concentration of the metabolite, E23S17G, which readily refurnished E217G via desulfation. Copyright © 2010 by The American Society for Pharmacology and Experimental Therapeutics